Professional Documents
Culture Documents
Medical Problems and Oral Care of Patients With Down Syndrome: A Literature Review
Medical Problems and Oral Care of Patients With Down Syndrome: A Literature Review
net/publication/51787356
Medical problems and oral care of patients with Down syndrome: A literature
review
CITATIONS READS
41 572
6 authors, including:
Some of the authors of this publication are also working on these related projects:
Avaliação de parâmetros de interesse odontológico em crianças e adolescentes com deficiência View project
All content following this page was uploaded by Ana Lídia Ciamponi on 29 February 2020.
M E D I C A L P R O B L E M S O F PAT I E N T S W I T H D O W N S Y N D R O M E
ARTICLE
Introduction
Down syndrome (DS) represents the most common chromosomal abnormality associated
with intellectual impairment. It affects an estimated 1 in 800 births or 5,400 infants in
the United States each year.1
In addition to intellectual disability, motor disorders, and dismorphologies, individ-
uals with DS present with medical conditions such as cardiovascular, immunological,
hematological, respiratory, neurological, and musculoskeletal abnormalities.2 Patients
with DS also have a higher prevalence of dysfunction within certain organs, such as the
esophagus and thyroid gland.2
©2011 Special Care Dentistry Association and Wiley Periodicals, Inc. S p e c C a re D e n t i s t 3 1 ( 6 ) 2 0 1 1 197
doi: 10.1111/j.1754-4505.2011.00211.x
scd_211.qxd 10/21/11 5:38 PM Page 198
M E D I C A L P R O B L E M S O F PAT I E N T S W I T H D O W N S Y N D R O M E
198 S p e c C a re D e n t i s t 3 1 ( 6 ) 2 0 1 1 M e d i c a l p ro b l e m s o f p a t i e n t s w i t h D o w n s y n d ro m e
scd_211.qxd 10/21/11 5:38 PM Page 199
M E D I C A L P R O B L E M S O F PAT I E N T S W I T H D O W N S Y N D R O M E
Table 2. Antibiotic prophylaxis regimen for dental procedures. time of diagnosis and during treatment.24
Such oral complications can be divided
To be Single dose 30–60 minutes into three groups.24,25 Primary lesions are
Situation Drug
administered before procedure
caused by infiltration of malignant cells
Adults Children into oral structures such as the gingiva
and bone. Secondary lesions are the
Normal Orally Amoxicillin 2g 50 mg/kg of body weight
result of the myelophthisic character of
Cephalexin or the disease and include symptoms of
Allergic to 2g 50 mg/kg of body weight
Clindamycin or anemia, increased tendency to bleed, and
penicillin or Orally 600 mg 20 mg/kg of body weight
Azithromycin or increased susceptibility to infection.
ampicillin 500 mg 15 mg/kg of body weight
Clarithromycin Tertiary lesions are induced by the
patients’ antileukemia treatment. The
Intramuscularly Ampicillin or
Unable to take 2g 50 mg/kg of body weight most common symptom detected is
or Cefazolin or
oral medication 1g 50 mg/kg of body weight mucosal pallor. Hemorrhage of the gin-
intravenously Ceftriaxone
giva, petechiae, and ecchymosis of the
Allergic to oral mucosa are due to thrombocytope-
penicillin or Intramuscularly Cefazolin or
1g 50 mg/kg of body weight
nia, platelet defects, capillary fragility,
ampicillin and or Ceftriaxone or and abnormal coagulation factors.24
600 mg 20 mg/kg of body weight
unable to take intravenously Clindamycin There is no indication that oral hygiene
oral medication
should be discontinued during the treat-
ment of patients with leukemia. In
patients who are capable of maintaining
levels of lymphocytes.15,16 Impaired T-cell described in patients with DS, a careful oral hygiene, this procedure seems to be
function is associated with low CD4 medical history should be taken and ver- an appropriate way of avoiding the devel-
numbers. Autoimmune disease occurs ification of leukocytes and platelet levels opment of oral problems without
with antithyroid, antigliadin, and anticar- in the blood should be done before initi- increasing the risk of infection.25
diolipin antibodies, contributing to ating any invasive dental procedures.
worsening immunoglobulin function
with age.17 Esophageal dysfunctions
Several studies18-20 demonstrate that Hematological Gastric dysfunctions like gastroe-
hepatitis B virus (HBV) infections are sophageal reflux and vomiting are
more prevalent among individuals with a bnor malities frequent findings in individuals with DS
DS (40%). Institutionalization and a pre- Newborns and children with DS may (13.8% to 59%).26,27 The symptoms of
disposition for infection are two factors present with many hematological prob- these dysfunctions are generally not
that may explain elevated levels of lems, particularly an increased risk of readily evident due to patients’ difficulty
chronic HBV infections in patients with leukemia.21 For individuals with DS in expressing themselves, which may
DS, which are seen as the presence of between the ages of 5 and 30 years, the hinder the clinical assessment of the
HBV surface antigens (HbsAg) in their risk increases approximately 12-fold for problem and delay diagnosis.27
serum.18 Therefore, HBV vaccination is developing acute lymphoblastic One study28 showed that tooth wear,
highly advisable for patients with DS leukemia; that risk rises to approxi- mainly dental erosion, was significantly
because of the significant risk of becom- mately 40-fold in children younger than more frequent among persons with DS
ing a chronic HBV carrier once 5 years.21 There is also a unique predis- (67%) than in the general population of
infected.19 It is particularly important in position to transient neonatal leukemia children of a similar age (34%). Most of
preschool children who constitute the (10%), known as transient abnormal the children with DS showed severe to
most susceptible group and where the myelopoiesis.22 The etiological role of very severe wear associated with gastric
response to immunization is more effec- the additional chromosome 21 in the reflux and vomiting.28 Given the poten-
tive.20 However, hepatitis B vaccination development of leukemia is supported tial consequences of high levels of tooth
in children remains low in several coun- by the observation that leukemic cells of wear associated with an acidic oral envi-
tries19; therefore it is important to young children with trisomy 21 ronment, dentists need to develop
reinforce the idea that vaccination mosaicism selectively involve the tri- educational programs aimed at increas-
against hepatitis B in preschool children somic cells. Several genes on ing awareness of this problem among
with DS is effective despite their existing chromosome 21 have been found to be caregivers and health professionals.
immune function abnormalities. disrupted in leukemia.23 Since the symptoms of esophageal dys-
Due to the high incidence of Leukemia is characterized by a high function are not always evident in
immunological alterations previously incidence of oral complications at the patients with DS, when dentists detect
M E D I C A L P R O B L E M S O F PAT I E N T S W I T H D O W N S Y N D R O M E
200 S p e c C a re D e n t i s t 3 1 ( 6 ) 2 0 1 1 M e d i c a l p ro b l e m s o f p a t i e n t s w i t h D o w n s y n d ro m e
scd_211.qxd 10/21/11 5:38 PM Page 201
M E D I C A L P R O B L E M S O F PAT I E N T S W I T H D O W N S Y N D R O M E
M E D I C A L P R O B L E M S O F PAT I E N T S W I T H D O W N S Y N D R O M E
children and adolescents in 10 regions of 13. Forner L, Larsen T, Kilian M, Holmstrup P. 27. Zárate N, Mearin F, Hidalgo A, Malagelada
the United States. Pediatrics 2009;124:1565- Incidence of bacteremia after chewing, tooth JR. Prospective evaluation of esophageal
71. brushing and scaling in individuals with motor dysfunction in Down’s syndrome. Am
2. Henderson A, Lynch SA, Wilkinson S, periodontal inflammation. J Clin Periodontol J Gastroenterol 2001;96:1718-24.
Hunter M. Adults with Down’s syndrome: 2006;33:401-7. 28. Bell EJ, Kaidonis J, Townsend GC. Tooth
the prevalence of complications and health 14. Fiske J, Shafik HH. Down’s syndrome and wear in children with Down syndrome. Aust
care in the community. Br J Gen Pract oral care. Dent Update 2001;28:148-56. Dent J 2002;47:30-5.
2007;57:50-5. 15. Hill DA, Gridley G, Cnattingius S, et al. 29. Bloemers BL, Broers CJ, Bont L, Weijerman
3. Vida VL, Barnoya J, Larrazabal LA, Gaitan Mortality and cancer incidence among indi- ME, Gemke RJ, van Furth AM. Increased
G, de Maria Garcia F, Castañeda AR. viduals with Down syndrome. Arch Intern risk of respiratory tract infections in chil-
Congenital cardiac disease in children with Med 2003;163:705-11. dren with Down syndrome: the consequence
Down’s syndrome in Guatemala. Cardiol 16. Byard RW. Forensic issues in Down syn- of an altered immune system. Microbes Infect
Young 2005;15:286-90. drome fatalities. J Forensic Leg Med 2010;12:799-808.
4. Jaiyesimi O, Baichoo V. Cardiovascular mal- 2007;14:475-81. 30. American Academy of Pediatrics, Committee
formations in Omani Arab children with 17. de Hingh YC, van der Vossen PW, Gemen on Genetics. Health supervision for children
Down’s syndrome. Cardiol Young EF, et al. Intrinsic abnormalities of lympho- with Down syndrome. Pediatrics
2007;17:166-71. cyte counts in children with Down 2001;107:442-9.
5. Freeman SB, Bean LH, Allen EG, et al. syndrome. J Pediatr 2005;147:744-7. 31. Galli M, Rigoldi C, Brunner R, Virji-Babul
Ethnicity, sex, and the incidence of congeni- 18. Percy ME, Potyomkina Z, Dalton AJ, et al. N, Giorgio A. Joint stiffness and gait pattern
tal heart defects: a report from the National Relation between apolipoprotein E geno- evaluation in children with Down syndrome.
Down Syndrome Project. Genet Med type, hepatitis B virus status, and thyroid Gait Posture 2008;28:502-6.
2008;10:173-80. status in a sample of older persons with 32. Limbrock GJ, Fischer-Brandies H, Avalle C.
6. Yamaki S, Yasui H, Kado H, et al. Pulmonary Down syndrome. Am J Med Genet A Castillo-Morales’ orofacial therapy: treat-
vascular disease and operative indications in 2003A;120:191-8. ment of 67 children with Down syndrome.
complete atrioventricular canal defect in 19. Troisi CL, Heiberg DA, Hollinger FB. Dev Med Child Neurol 1991;33:296-303.
early infancy. J Thorac Cardiovasc Surg Normal immune response to hepatitis B vac- 33. Gatenby P, Tucko R, Andrews C, O’Neil R.
1993;106:398-405. cine in patients with Down’s syndrome. A Antiphospholipid antibodies and stroke in
7. Ono M, Goerler H, Boethig D, et al. basis for immunization guidelines. JAMA Down syndrome. Lupus 2003;12:58-62.
Improved results after repair of complete 1985;254:3196-9. 34. Margallo-Lana ML, Moore PB, Kay DW, et al.
atrioventricular septal defect. J Card Surg 20. Rua Armesto MJ, Ramrez Marn V, Fifteen-year follow-up of 92 hospitalized
2009;24:732-7. Onaindia Ercoreca MT, Garca Aguado J, adults with Down’s syndrome: incidence of
8. Wilson W, Taubert KA, Gewitz M, et al. Ruiz Moreno M. Predisposition of Down cognitive decline, its relationship to age and
AHA Guideline. Prevention of infective syndrome to chronic infection with the hep- neuropathology. J Intellect Disabil Res
endocarditis: guidelines from the American atitis B virus. An Esp Pediatr 1993; 2007;51:463-77.
Heart Association. Circulation 38:529-31. 35. McKee JR, Bodfish JW. Sudden expected
2007;116:1736-54. 21. Webb D, Roberts I, Vyas P. Haematology of death in epilepsy in adults with mental
9. Tempe DK, Virmani S. Coagulation abnor- Down syndrome. Arch Dis Child Fetal retardation. Am J Ment Retard 2000;105:229-
malities in patients with cyanotic congenital Neonatal Ed 2007;92:F503-7. 35.
heart disease. J Cardiothorac Vasc Anesth 22. Henderson R, Spence L. Down syndrome 36. Henry RG, Wekstein DR. Providing dental
2002;16:752-65. with myelodysplasia of megakaryoblastic care for patients diagnosed with Alzheimer’s
10. Butler MG, Hayes BG, Hathaway MM, lineage. Clin Lab Sci 2006;19:161-4. disease. Dent Clin North Am 1997;41:915-43.
Begleiter ML. Specific genetic diseases at 23. Hasle H, Clemmensen IH, Mikkelsen M. 37. Karlsson B, Gustafsson J, Hedov G, Ivarsson
risk for sedation/anesthesia complications. Risks of leukaemia and solid tumours indi- SA, Annern G. Thyroid dysfunction in
Anesth Analg 2000;91:837-55. viduals with Down’s syndrome. Lancet Down’s syndrome: relation to age and thy-
11. Hoffman JIE. Incidence, mortality, and natu- 2000;335:165-9. roid autoimmunity. Arch Dis Child
ral history. In Anderson RH, Baker EJ 24. Genc A, Atalay T, Gedikoglu G, Zulfikar B, 1998;79:242-5.
McCartney FJ, Rigby ML, Shinebourne EA, Kullu S. Leukemic children: clinical and 38. Nicholson LB, Wong FS, Ewins DL, et al.
Tynan M, eds. Paediatric cardiology. 2nd ed. histopathological gingival lesions. J Clin Susceptibility to autoimmune thyroiditis in
London: Churchill Livingstone; 2002:111- Pediatr Dent 1998;22:253-6. Down’s syndrome is associated with the
31. 25. Orbak R, Orbak Z. Oral condition of major histocompatibility class II DQA 0301
12. Johnstone SC, Barnard KM, Harrison VE. patients with leukemia and lymphoma. J allele. Clin Endocrinol 1994;41:381-3.
Recognizing and caring for the medically Nihon Univ Sch Dent 1997;39:67-70. 39. Huber MA, Terzhalmy GT. Risk stratification
compromised child: 4. Children with other 26. Mitchell RB, Call E, Kelly J. Ear, nose and and dental management of the patient with
chronic medical conditions. Dent Update throat disorders in children with Down syn- thyroid dysfunction. Quintessence Int
1999;26:21-6. drome. Laryngoscope 2003;113:259-63. 2008;39:139-50.
202 S p e c C a re D e n t i s t 3 1 ( 6 ) 2 0 1 1 M e d i c a l p ro b l e m s o f p a t i e n t s w i t h D o w n s y n d ro m e
scd_211.qxd 10/21/11 5:38 PM Page 203
M E D I C A L P R O B L E M S O F PAT I E N T S W I T H D O W N S Y N D R O M E
40. Homestead Schools, Inc. www.homestead complications. Diabet Med 1998;15: syndrome: a cross-sectional study. BMC
schools.com. Accessed February 5, 2011. 160-3. Endocr Disord 2005;5:6.
41. Anwar AJ, Walker JD, Frier BM. Type 1 42. Fonseca CT, Amaral DM, Ribeiro MG, 43. Ryan ME. Diagnostic and therapeutic strategies
diabetes mellitus and Down’s syndrome: Beserra IC, Guimarães MM. Insulin for the management of the diabetic patient.
prevalence, management and diabetic resistance in adolescents with Down Compend Contin Educ Dent 2008;29:32-8.